Viraday Tablets

Viraday Tablets Specification

Salt Composition
Tenofovir Disoproxil Fumarate 300 mg, Emtricitabine 200 mg, Efavirenz 600 mg

Dosage Form
Tablet

Indication
HIV-1 infection in adults

Origin
India

Enzyme Types
Viraday Tablets

Feature
Once-daily fixed-dose combination; convenient for patient compliance

Ingredients
Tenofovir Disoproxil Fumarate, Emtricitabine, Efavirenz, Excipients

Application
Antiretroviral therapy for HIV treatment

Physical Color/Texture
Yellow colored, capsule-shaped film-coated tablet

Fermentation Smell
Odorless or characteristic pharmaceutical smell

Storage Instructions
Cool & Dry Place

Shelf Life
24-36 months (as per manufacturer and country regulations)

Administration Route
Oral

Pack Size
30 tablets per bottle

Brand Name
Viraday

Warning
Not for use in patients with known hypersensitivity to any component; use caution in patients with renal or hepatic impairment

Box Dimensions (Approximate)
11.8 x 6.1 x 5.3 cm

Tablet Marking
Embossed with 'C' on one side and plain on the other

Prescription Status
Prescription only

Market Availability
Supplied in multiple countries under regulated distribution

Gross Weight (per unit)
Approx. 130 g

Viraday Tablets Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
100 Pieces Per Day

Delivery Time
2 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Viraday Tablets

Viraday Tablet is used in the treatment of HIV infection.Viraday Tablet is a combination of three antiviral medicines Emtricitabine, Tenofovir and Efavirenz. They work by preventing HIV (virus) from multiplying, thereby reducing the amount of virus in your body. They also increase the CD4 cell (white blood cells that protect against infection) count in your blood.

Comprehensive HIV-1 Therapy in One Tablet

Viraday Tablets offer a convenient, fixed-dose combination of three potent antiretroviral agents-Tenofovir, Emtricitabine, and Efavirenz. This once-daily regimen is designed to improve adherence and streamline treatment for adults managing HIV-1 infection. The unique formulation supports effective viral suppression while maintaining patient compliance.

Quality, Safety, and International Supply

Manufactured in India and distributed globally, Viraday strictly follows international regulatory standards. Each bottle contains 30 tablets, matching market requirements for consistent monthly therapy. The tablets remain potent for 24-36 months when stored properly, ensuring availability and quality for patients worldwide.

Patient-Friendly Features and Administration

Viraday's oral and once-daily administration simplifies treatment routines. Tablets are yellow, capsule-shaped, and film-coated, with a characteristic design for easy identification. Patients should take Viraday as prescribed by their healthcare provider and keep it stored in a cool, dry place to preserve efficacy.

FAQ's of Viraday Tablets:

Q: How should Viraday Tablets be taken for optimal effectiveness?

A: Viraday Tablets should be taken orally once daily, exactly as prescribed by your healthcare provider. Consistency at the same time each day helps maintain effective drug levels in your body and improves treatment outcomes.

Q: What conditions are Viraday Tablets indicated for?

A: Viraday is primarily indicated for the treatment of HIV-1 infection in adult patients as part of antiretroviral therapy. It is not suitable for treating other forms of HIV or infections.

Q: When is it necessary to avoid or use caution with Viraday Tablets?

A: You should avoid Viraday if you have a known hypersensitivity to any of its components. Use caution and consult your doctor if you have renal or hepatic impairment before initiating therapy.

Q: Where are Viraday Tablets manufactured and distributed?

A: Viraday Tablets are manufactured in India and are supplied internationally under regulated distribution channels to ensure patient safety and quality.

Q: What is the process for obtaining Viraday Tablets?

A: Viraday is a prescription-only medication. Patients must consult a licensed healthcare provider, who will determine the appropriateness of Viraday and issue a prescription if indicated.

Q: What are the benefits of Viraday's once-daily fixed-dose combination?

A: The once-daily dosing of Viraday simplifies complex antiretroviral regimens, improving patient compliance and supporting sustained viral suppression in HIV-1 therapy.

Tell us about your requirement